XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls | Zendy

Liang Zhang | Zendy; Yan Wang | Zendy; Zhiqun Qiu | Zendy; Jiaohua Luo | Zendy; Ziyuan Zhou | Zendy; Weiqun Shu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls

Author(s) -

Liang Zhang,

Yan Wang,

Zhiqun Qiu,

Jiaohua Luo,

Ziyuan Zhou,

Weiqun Shu

Publication year - 2012

Publication title -

pakistan journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.316

H-Index - 30

eISSN - 1682-024X

pISSN - 1681-715X

DOI - 10.12669/pjms.291.2694

Subject(s) - medicine , meta analysis , xrcc1 , glioma , oncology , bioinformatics , genetics , single nucleotide polymorphism , cancer research , genotype , gene , biology

Previous reports indicated that XRCC1 Arg280His polymorphism might be a possible risk factor for several cancers. Published studies on the association of XRCC1 Arg280His polymorphisms with glioma risk have yielded controversial results. The present study aimed to derive a more precise estimation of the relationship.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research